Cited by 48

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration

Wallach, Thomas, Mossmann, Zoé J., Szczepek, Michal, Wetzel, Max, Machado, Rui, Raden, Martin, Miladi, Milad, Kleinau, Gunnar, Krüger, Christina, Dembny, Paul, Adler, Drew, Zhai, Yuanyuan, Kumbol, Victor, Dzaye, Omar, Schüler, Jutta, Futschik, Matthias, Backofen, Rolf, Scheerer, Patrick, Lehnardt, Seija·2021·Molecular Neurodegeneration

Abstract

Background: MicroRNA (miRNA) expression in the brain is altered in neurodegenerative diseases. Recent studies demonstrated that selected miRNAs conventionally regulating gene expression at the post-transcriptional level can act extracellularly as signaling molecules. The identity of miRNA species serving as membrane receptor ligands involved in neuronal apoptosis in the central nervous system (CNS), as well as the miRNAs’ sequence and structure required for this mode of action remained largely unresolved. Methods: Using a microarray-based screening approach we analyzed apoptotic cortical neurons of C56BL/6 mice and their supernatant with respect to alterations in miRNA expression/presence. HEK-Blue Toll-like receptor (TLR) 7/8 reporter cells, primary microglia and macrophages derived from human and mouse were employed to test the potential of the identified miRNAs released from apoptotic neurons to serve as signaling molecules for the RNA-sensing receptors. Biophysical and bioinformatical approaches, as well as immunoassays and sequential microscopy were used to analyze the interaction between candidate miRNA and TLR. Immunocytochemical and -histochemical analyses of murine CNS cultures and adult mice intrathecally injected with miRNAs, respectively, were performed to evaluate the impact of miRNA-induced TLR activation on neuronal survival and microglial activation. Results: We identified a specific pattern of miRNAs released from apoptotic cortical neurons that activate TLR7 and/or TLR8, depending on sequence and species. Exposure of microglia and macrophages to certain miRNA classes released from apoptotic neurons resulted in the sequence-specific production of distinct cytokines/chemokines and increased phagocytic activity. Out of those miRNAs miR-100-5p and miR-298-5p, which have consistently been linked to neurodegenerative diseases, entered microglia, located to their endosomes, and directly bound to human TLR8. The miRNA-TLR interaction required novel sequence features, but no specific structure formation of mature miRNA. As a consequence of miR-100-5p- and miR-298-5p-induced TLR activation, cortical neurons underwent cell-autonomous apoptosis. Presence of miR-100-5p and miR-298-5p in cerebrospinal fluid led to neurodegeneration and microglial accumulation in the murine cerebral cortex through TLR7 signaling. Conclusion: Our data demonstrate that specific miRNAs are released from apoptotic cortical neurons, serve as endogenous TLR7/8 ligands, and thereby trigger further neuronal apoptosis in the CNS. Our findings underline the recently discovered role of miRNAs as extracellular signaling molecules, particularly in the context of neurodegeneration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13024-021-00498-5

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 61

  1. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol. 2010;11(5):373–84. https://doi.org/10.1038/ni.1863 Epub 2010/04/21. PubMed PMID: 20404851. · DOI · Paper page
  2. Cameron JS, Alexopoulou L, Sloane JA, DiBernardo AB, Ma Y, Kosaras B, et al. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci. 2007;27(47):13033–41. https://doi.org/10.1523/jneurosci.4290-06.2007. · DOI
  3. Lehmann SM, Kruger C, Park B, Derkow K, Rosenberger K, Baumgart J, et al. An unconventional role for miRNA: let-7 activates toll-like receptor 7 and causes neurodegeneration. Nat Neurosci. 2012;15(6):827–35. https://doi.org/10.1038/nn.3113 Epub 2012/05/23. PubMed PMID: 22610069. · DOI · Paper page
  4. Lehmann SM, Rosenberger K, Krüger C, Habbel P, Derkow K, Kaul D, et al. Extracellularly delivered single-stranded viral RNA causes neurodegeneration dependent on TLR7. J Immunol. 2012;189(3):1448. https://doi.org/10.4049/jimmunol.1201078. · DOI · Paper page
  5. Jurk M, Heil F, Vollmer J, Schetter C, Krieg AM, Wagner H, et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol. 2002;3(6):499. https://doi.org/10.1038/ni0602-499. · DOI · Paper page
  6. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303(5663):1526–9 PubMed PMID: 14976262. · DOI · Paper page
  7. Forsbach A, Nemorin JG, Montino C, Muller C, Samulowitz U, Vicari AP, et al. Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses. J Immunol. 2008;180(6):3729–38 Epub 2008/03/07. PubMed PMID: 18322178. · DOI · Paper page
  8. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, et al. Recognition of single-stranded RNA viruses by toll-like receptor 7. Proc Natl Acad Sci U S A. 2004;101(15):5598–603. https://doi.org/10.1073/pnas.0400937101 Epub 2004/03/23. PubMed PMID: 15034168; PubMed Central PMCID: PMC397437. · DOI
  9. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92–105. https://doi.org/10.1101/gr.082701.108 Epub 2008/10/29. PubMed PMID: 18955434; PubMed Central PMCID: PMCPMC2612969. · DOI · Paper page
  10. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A. 2012;109(31):E2110–6. https://doi.org/10.1073/pnas.1209414109 Epub 2012/07/04. PubMed PMID: 22753494; PubMed Central PMCID: PMCPMC3412003. · DOI · Paper page
  11. He S, Chu J, Wu L-C, Mao H, Peng Y, Alvarez-Breckenridge CA, et al. MicroRNAs activate natural killer cells through toll-like receptor signaling. Blood. 2013;121(23):4663–71. https://doi.org/10.1182/blood-2012-07-441360. · DOI
  12. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–9. https://doi.org/10.1038/ncb1596 Epub 2007/05/09. PubMed PMID: 17486113. · DOI · Paper page
  13. Derkow K, Rossling R, Schipke C, Kruger C, Bauer J, Fahling M, et al. Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer's disease. PLoS One. 2018;13(7):e0200602. https://doi.org/10.1371/journal.pone.0200602 PubMed PMID: 30011310; PubMed Central PMCID: PMCPMC6047809. · DOI
  14. Wang WX, Huang Q, Hu Y, Stromberg AJ, Nelson PT. Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol. 2011;121(2):193–205. https://doi.org/10.1007/s00401-010-0756-0 Epub 2010/10/12. PubMed PMID: 20936480; PubMed Central PMCID: PMCPMC3073518. · DOI · Paper page
  15. Saucier D, Wajnberg G, Roy J, Beauregard AP, Chacko S, Crapoulet N, et al. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Brain Res. 2019;1708:100–8. https://doi.org/10.1016/j.brainres.2018.12.016 Epub 2018/12/16. PubMed PMID: 30552897. · DOI · Paper page
  16. Freiesleben S, Hecker M, Zettl UK, Fuellen G, Taher L. Analysis of microRNA and gene expression profiles in multiple sclerosis: Integrating interaction data to uncover regulatory mechanisms. Sci Rep. 2016;6:34512. https://doi.org/10.1038/srep34512. · DOI
  17. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway. Proc Natl Acad Sci. 2003;100(14):8514. https://doi.org/10.1073/pnas.1432609100. · DOI · Paper page
  18. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci. 2002;22(7):2478–86 PubMed PMID: 11923412. · DOI
  19. Glynn CL, Khan S, Kerin MJ, Dwyer RM. Isolation of secreted microRNAs (miRNAs) from cell-conditioned media. MicroRNA. 2013;2(1):14–9. · DOI
  20. Wallach T, Wetzel M, Dembny P, Staszewski O, Krüger C, Buonfiglioli A, et al. Identification of CNS Injury-Related microRNAs as Novel Toll-Like Receptor 7/8 Signaling Activators by Small RNA Sequencing. Cells. 2020;9(1):1–20. · DOI · Paper page
  21. Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 2010;26(19):2363–7. https://doi.org/10.1093/bioinformatics/btq431 Epub 2010/08/07. PubMed PMID: 20688976; PubMed Central PMCID: PMCPMC2944196. · DOI
  22. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https://doi.org/10.1093/nar/gkv007 Epub 2015/01/22. PubMed PMID: 25605792; PubMed Central PMCID: PMCPMC4402510. · DOI · Paper page
  23. Tai YC, Speed TP. A multivariate empirical Bayes statistic for replicated microarray time course data. Ann Stat. 2006;34(5):2387–412. · DOI
  24. Wickham H. ggplot2. WIREs Comput Stat. 2011;3(2):180–5. https://doi.org/10.1002/wics.147. · DOI
  25. Sabour D, Machado RSR, Pinto JP, Rohani S, Sahito RGA, Hescheler J, et al. Parallel Genome-wide Profiling of Coding and Non-coding RNAs to Identify Novel Regulatory Elements in Embryonic and Maturated Heart. Mol Ther Nucleic Acids. 2018;12:158–73. https://doi.org/10.1016/j.omtn.2018.04.018 Epub 2018/09/10. PubMed PMID: 30195755; PubMed Central PMCID: PMCPMC6023836. · DOI
  26. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008;36(Database issue):D149–53. https://doi.org/10.1093/nar/gkm995 Epub 2007/12/26. PubMed PMID: 18158296; PubMed Central PMCID: PMCPMC2238905. · DOI
  27. Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2015;43(Database issue):D146–52. https://doi.org/10.1093/nar/gku1104 Epub 2014/11/08. PubMed PMID: 25378301; PubMed Central PMCID: PMCPMC4383922. · DOI
  28. Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4. https://doi.org/10.7554/eLife.05005 Epub 2015/08/13. PubMed PMID: 26267216; PubMed Central PMCID: PMCPMC4532895. · DOI · Paper page
  29. Chou CH, Chang NW, Shrestha S, Hsu SD, Lin YL, Lee WH, et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res. 2016;44(D1):D239–47. https://doi.org/10.1093/nar/gkv1258 Epub 2015/11/22. PubMed PMID: 26590260; PubMed Central PMCID: PMCPMC4702890. · DOI
  30. Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics. 2007;23(2):257–8. https://doi.org/10.1093/bioinformatics/btl567 Epub 2006/11/14. PubMed PMID: 17098774. · DOI
  31. Lian H, Roy E, Zheng H. Microglial Phagocytosis Assay. Bio-protocol. 2016;6(21):e1988. https://doi.org/10.21769/BioProtoc.1988. · DOI
  32. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82. https://doi.org/10.1038/nmeth.2019. · DOI · Paper page
  33. Buonfiglioli A, Efe IE, Guneykaya D, Ivanov A, Huang Y, Orlowski E, et al. Let-7 MicroRNAs regulate microglial function and suppress glioma growth through toll-like receptor 7. Cell Rep. 2019;29(11):3460–71 e7. https://doi.org/10.1016/j.celrep.2019.11.029 PubMed PMID: 31825829. · DOI · Paper page
  34. Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol. 2002;61(11):1013–21 PubMed PMID: 12430718. · DOI
  35. Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol. 2004;173(6):3916–24. https://doi.org/10.4049/jimmunol.173.6.3916. · DOI · Paper page
  36. Carson MJ, Crane J, Xie AX. Modeling CNS microglia: the quest to identify predictive models. Drug Discov Today Dis Models. 2008;5(1):19–25. https://doi.org/10.1016/j.ddmod.2008.07.006 PubMed PMID: 19444332. · DOI
  37. Zarember KA, Godowski PJ. Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol. 2002;168(2):554. https://doi.org/10.4049/jimmunol.168.2.554. · DOI
  38. Wang J, Shao Y, Bennett TA, Shankar RA, Wightman PD, Reddy LG. The functional effects of physical interactions among toll-like receptors 7, 8, and 9. J Biol Chem. 2006;281(49):37427–34. https://doi.org/10.1074/jbc.M605311200 Epub 2006/10/17. PubMed PMID: 17040905. · DOI
  39. Belter A, Gudanis D, Rolle K, Piwecka M, Gdaniec Z, Naskret-Barciszewska MZ, et al. Mature miRNAs form secondary structure, which suggests their function beyond RISC. PLoS One. 2014;9(11):e113848. https://doi.org/10.1371/journal.pone.0113848 Epub 2014/11/26. PubMed PMID: 25423301; PubMed Central PMCID: PMCPMC4244182. · DOI
  40. Lorenz R, Bernhart SH, Honer Zu Siederdissen C, Tafer H, Flamm C, Stadler PF, et al. ViennaRNA Package 2.0. Algorithms Mol Biol. 2011;6:26. https://doi.org/10.1186/1748-7188-6-26 Epub 2011/11/26. PubMed PMID: 22115189; PubMed Central PMCID: PMCPMC3319429. · DOI · Paper page
  41. Boissonneault V, Plante I, Rivest S, Provost P. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem. 2009;284(4):1971–81. https://doi.org/10.1074/jbc M807530200. PubMed PMID: 18986979; PubMed Central PMCID: PMCPMC2908704. · DOI
  42. Chopra N, Wang R, Maloney B, Nho K, Beck JS, Pourshafie N, et al. MicroRNA-298 reduces levels of human amyloid-beta precursor protein (APP), beta-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties. Mol Psychiatry. 2020. https://doi.org/10.1038/s41380-019-0610-2 Epub 2020/01/17. PubMed PMID: 31942037. · DOI
  43. Ye X, Luo H, Chen Y, Wu Q, Xiong Y, Zhu J, et al. MicroRNAs 99b-5p/100-5p Regulated by Endoplasmic Reticulum Stress are Involved in Abeta-Induced Pathologies. Front Aging Neurosci. 2015;7(210). https://doi.org/10.3389/fnagi.2015.00210. · DOI
  44. Lehnardt S, Schott E, Trimbuch T, Laubisch D, Krueger C, Wulczyn G, et al. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci. 2008;28(10):2320–31 PubMed PMID: 18322079. · DOI
  45. Rosenberger K, Dembny P, Derkow K, Engel O, Krüger C, Wolf SA, et al. Intrathecal heat shock protein 60 mediates neurodegeneration and demyelination in the CNS through a TLR4- and MyD88-dependent pathway. Mol Neurodegener. 2015;10(1):5. https://doi.org/10.1186/s13024-015-0003-1. · DOI
  46. Hara N, Kikuchi M, Miyashita A, Hatsuta H, Saito Y, Kasuga K, et al. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease. Acta Neuropathol Commun. 2017;5(1):10. https://doi.org/10.1186/s40478-017-0414-z Epub 2017/02/01. PubMed PMID: 28137310; PubMed Central PMCID: PMCPMC5282710. · DOI · Paper page
  47. Pigati L, Yaddanapudi SCS, Iyengar R, Kim D-J, Hearn SA, Danforth D, et al. Selective release of MicroRNA species from Normal and malignant mammary epithelial cells. PLoS One. 2010;5(10):e13515. https://doi.org/10.1371/journal.pone.0013515. · DOI
  48. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39(16):7223–33. https://doi.org/10.1093/nar/gkr254. · DOI · Paper page
  49. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418(6894):191–5. https://doi.org/10.1038/nature00858 Epub 2002/07/12. PubMed PMID: 12110890. · DOI · Paper page
  50. Park C-K, Xu Z-Z, Berta T, Han Q, Chen G, Liu X-J, et al. Extracellular MicroRNAs Activate Nociceptor Neurons to Elicit Pain via TLR7 and TRPA1. Neuron. 2014;82(1):47–54. https://doi.org/10.1016/j.neuron.2014.02.011. · DOI · Paper page
  51. Shimizu T. Structural insights into ligand recognition and regulation of nucleic acid-sensing toll-like receptors. Curr Opin Struct Biol. 2017;47:52–9. https://doi.org/10.1016/j.sbi.2017.05.010 Epub 2017/06/11. PubMed PMID: 28600980. · DOI
  52. Maeda K, Akira S. TLR7 structure: cut in Z-loop. Immunity. 2016;45(4):705–7. https://doi.org/10.1016/j.immuni.2016.10.003 Epub 2016/10/21. PubMed PMID: 27760331. · DOI
  53. Tanji H, Ohto U, Shibata T, Taoka M, Yamauchi Y, Isobe T, et al. Toll-like receptor 8 senses degradation products of single-stranded RNA. Nat Struct Mol Biol. 2015;22(2):109–15. https://doi.org/10.1038/nsmb.2943 Epub 2015/01/20. PubMed PMID: 25599397. · DOI · Paper page
  54. Zhang Z, Ohto U, Shibata T, Taoka M, Yamauchi Y, Sato R, et al. Structural analyses of toll-like receptor 7 reveal detailed RNA sequence specificity and recognition mechanism of agonistic ligands. Cell Rep. 2018;25(12):3371–81 e5. https://doi.org/10.1016/j.celrep.2018.11.081 Epub 2018/12/20. PubMed PMID: 30566863. · DOI
  55. Ginsberg SD, Crino PB, Lee VM, Eberwine JH, Trojanowski JQ. Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques. Ann Neurol. 1997;41(2):200–9. https://doi.org/10.1002/ana.410410211 Epub 1997/02/01. PubMed PMID: 9029069. · DOI
  56. Luo H, Wu Q, Ye X, Xiong Y, Zhu J, Xu J, et al. Genome-wide analysis of miRNA signature in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease. PLoS One. 2014;9(8):e101725. https://doi.org/10.1371/journal.pone.0101725. · DOI
  57. Préhaud C, Mégret F, Lafage M, Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of Beta interferon. J Virol. 2005;79(20):12893–904. https://doi.org/10.1128/jvi.79.20.12893-12904.2005. · DOI
  58. Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, et al. Role of the toll-like receptor 4 in Neuroinflammation in Alzheimer’s disease. Cell Physiol Biochem. 2007;20(6):947–56. https://doi.org/10.1159/000110455. · DOI · Paper page
  59. Donnelly CR, Chen O, Ji R-R. How Do Sensory Neurons Sense Danger Signals? Trends Neurosci. 2020;43(10):822–38. https://doi.org/10.1016/j.tins.2020.07.008. · DOI
  60. McCullough T. Avogadro's number, moles, and molecules. J Chem Educ. 1990;67(9):783. https://doi.org/10.1021/ed067p783. · DOI
  61. Alexandrov PN, Dua P, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ. microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int J Biochem Mol Biol. 2012;3(4):365–73 Epub 2012/12/24. PubMed PMID: 23301201.

Cited by

Sorted by citations

Metadata

Authors
Wallach, T., Mossmann, Z. J., Szczepek, M., Wetzel, M., Machado, R., Raden, M., Miladi, M., Kleinau, G., Krüger, C., Dembny, P., Adler, D., Zhai, Y., Kumbol, V., Dzaye, O., Schüler, J., Futschik, M., Backofen, R., Scheerer, P., & Lehnardt, S.
Venue
Molecular Neurodegeneration
Published
2021-11-27
Volume
16
Issue
1
ISSN
1750-1326
Cited by
48
References
9
Language
en
Funders
  • deutsche forschungsgemeinschaft (NeuroCure Exc 257, LE 2420/2-1, SFB-TRR 167/B03, BA 2168/16-1, BA 2168/21-1, BA 2168/3-3, CRC 1078/B6, CRC 1423)
  • germany‘s excellence strategy (CIBSS-EXC-2189-Project ID 390939984)
  • Charité - Universitätsmedizin Berlin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review